1. Home
  2. GPMT vs ENTX Comparison

GPMT vs ENTX Comparison

Compare GPMT & ENTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Granite Point Mortgage Trust Inc.

GPMT

Granite Point Mortgage Trust Inc.

HOLD

Current Price

$1.41

Market Cap

71.9M

Sector

Real Estate

ML Signal

HOLD

Logo Entera Bio Ltd.

ENTX

Entera Bio Ltd.

HOLD

Current Price

$1.22

Market Cap

58.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GPMT
ENTX
Founded
2015
2010
Country
United States
Israel
Employees
28
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
71.9M
58.2M
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
GPMT
ENTX
Price
$1.41
$1.22
Analyst Decision
Buy
Strong Buy
Analyst Count
2
1
Target Price
$3.00
$9.00
AVG Volume (30 Days)
157.2K
58.7K
Earning Date
05-05-2026
05-14-2026
Dividend Yield
12.99%
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.07
Revenue
N/A
$42,000.00
Revenue This Year
$458.85
N/A
Revenue Next Year
$8.63
N/A
P/E Ratio
N/A
$17.29
Revenue Growth
N/A
N/A
52 Week Low
$1.24
$0.91
52 Week High
$3.12
$3.22

Technical Indicators

Market Signals
Indicator
GPMT
ENTX
Relative Strength Index (RSI) 39.78 49.46
Support Level $1.24 $1.17
Resistance Level $1.58 $1.37
Average True Range (ATR) 0.07 0.06
MACD -0.01 -0.00
Stochastic Oscillator 18.87 27.27

Price Performance

Historical Comparison
GPMT
ENTX

About GPMT Granite Point Mortgage Trust Inc.

Granite Point Mortgage Trust Inc focuses on directly originating, investing in, and managing senior floating rate commercial mortgage loans and other debt and debt-like commercial real estate investments. The company constructs its investment portfolio on a loan-by-loan basis, emphasizing rigorous credit underwriting, selectivity, and diversification, and assesses each investment from a fundamental value perspective relative to other opportunities available in the market. It typically provides intermediate-term bridge or transitional financing for a variety of purposes, including acquisitions, recapitalizations, refinancing, and a range of business plans, including lease-up, renovation, repositioning and repurposing of the commercial property.

About ENTX Entera Bio Ltd.

Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to perform. Its product candidates are: EB613, which is being developed as an oral, osteoanabolic (bone-building) tablet treatment for osteoporosis; EB612, being developed as an oral PTH(1-34) tablet peptide replacement therapy for patients with hypoparathyroidism; EB618, an Oral GLP-1 being developed to tackle obesity; and Oral GLP-2, a peptide tablet alternative for patients suffering from short bowel syndrome. The company operates in Israel.

Share on Social Networks: